AI-Powered MRI could eliminate need for brain tumor biopsies
NCT ID NCT04313140
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether artificial intelligence can determine the grade of a brain tumor (glioma) from MRI scans alone, a so-called 'virtual biopsy.' Researchers will compare AI results with traditional tissue biopsies in 500 adults with suspected glioma. If accurate, this could make diagnosis faster and less invasive.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a non-invasive way to diagnose brain tumor grade using MRI, avoiding the need for surgical biopsy.
- What could go wrong
- This is an early-stage diagnostic study, not a treatment. The AI may not be accurate enough to replace biopsy, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE ALGORITHMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU De Poitiers
RECRUITINGPoitiers, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a sharper beam of radiation shield the mind during brain tumor treatment?
- Can a tiny implant trap brain tumor cells and make radiation work better?
- Can a targeted pill slow brain tumor growth after surgery?
- Brain surgery gets a GPS: network maps may help remove tumors while preserving function